These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 7524143)

  • 1. Prostatic enlargement, symptomatology and pressure/flow evaluation: interrelations in patients with symptomatic BPH.
    Poulsen AL; Schou J; Puggaard L; Torp-Pedersen S; Nordling J
    Scand J Urol Nephrol Suppl; 1994; 157():67-73. PubMed ID: 7524143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ultrasound indicators of the prostate, urinary bladder and uroflowmetry parameters in the diagnosis of infravesical obstruction in men with benign prostatic hyperplasia].
    Krivoborodov GG; Efremov NS; Bolotov AD
    Urologiia; 2017 Oct; (5):9-14. PubMed ID: 29135135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive patient evaluation for benign prostatic hyperplasia.
    Jepsen JV; Bruskewitz RC
    Urology; 1998 Apr; 51(4A Suppl):13-8. PubMed ID: 9586591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of the Danish Prostate Symptom Score compared to the AUA symptom score and pressure/flow studies in the preoperative evaluation of men with symptomatic benign prostatic hyperplasia.
    Pannek J; Berges RR; Haupt G; Senge T
    Neurourol Urodyn; 1998; 17(1):9-18. PubMed ID: 9453687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of high bladder neck elevation with urodynamic bladder outlet obstruction in patients with lower urinary tract symptoms and benign prostatic hyperplasia.
    Kang M; Kim M; Choo MS; Bae J; Ku JH; Yoo C; Oh SJ
    Urology; 2014 Dec; 84(6):1461-6. PubMed ID: 25432841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urodynamics in benign prostatic hyperplasia (BPH).
    Schäfer W
    Arch Ital Urol Androl; 1993 Dec; 65(6):599-613. PubMed ID: 7508790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis of infravesical obstruction in patients with benign prostatic hyperplasia].
    Al'-Shukri SKh; Amdiĭ RE
    Urologiia; 2006; (2):41-3, 45. PubMed ID: 16708588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic values and limitations of conventional urodynamic studies (uroflowmetry.residual urine measurement.cystometry) in benign prostatic hypertrophy].
    Gotoh M; Yoshikawa Y; Kondo A; Kato N; Ono Y; Kondo T; Nagai T; Sakakibara T; Kondo A; Miyake K
    Nihon Hinyokika Gakkai Zasshi; 1996 Dec; 87(12):1321-30. PubMed ID: 8997080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Latest trends and recommendations on epidemiology, diagnosis, and treatment of benign prostatic hyperplasia (BPH)].
    Gabuev A; Oelke M
    Aktuelle Urol; 2011 May; 42(3):167-78. PubMed ID: 21604233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age related urodynamic changes in patients with benign prostatic hyperplasia.
    Madersbacher S; Klingler HC; Schatzl G; Stulnig T; Schmidbauer CP; Marberger M
    J Urol; 1996 Nov; 156(5):1662-7. PubMed ID: 8863566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between the International Prostatic Symptom Score and a pressure-flow study in the evaluation of symptomatic benign prostatic hyperplasia.
    Netto Júnior NR; D'Ancona CA; de Lima ML
    J Urol; 1996 Jan; 155(1):200-2. PubMed ID: 7490834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Objective and subjective response criteria to diagnose benign prostatic hyperplasia.
    Roehrborn CG
    Eur Urol; 1993; 24 Suppl 1():2-11. PubMed ID: 7687554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study evaluating a new questionnaire for prostatic symptom scoring, the SPSS, and its sensitivity as constructed to objective measures of outflow obstruction.
    Yano M; Kitahara S; Yasuda K; Yamanishi T; Nakai H; Yanagisawa R; Morozumi M; Homma Y
    Int J Urol; 2004 May; 11(5):288-94. PubMed ID: 15147544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doppler resistive index in benign prostatic hyperplasia: correlation with ultrasonic appearance of the prostate and infravesical obstruction.
    Kojima M; Ochiai A; Naya Y; Okihara K; Ukimura O; Miki T
    Eur Urol; 2000 Apr; 37(4):436-42. PubMed ID: 10765074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of functional examination techniques for the assessment of the clinical aspects of benign prostatic hyperplasia].
    Hohenfellner M; Thüroff JW
    Urologe A; 1992 May; 31(3):142-9. PubMed ID: 1377431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transurethral vaporization of the prostate in the treatment of bladder outlet obstruction at two university hospitals.
    Gerber GS; Jahoda A; Bales GT; Albala DM
    Tech Urol; 1997; 3(1):25-9. PubMed ID: 9170221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The overlooked cause of benign prostatic hyperplasia: prostatic urethral angulation.
    Cho KS; Kim J; Choi YD; Kim JH; Hong SJ
    Med Hypotheses; 2008; 70(3):532-5. PubMed ID: 17761390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similarity of the American Urological Association Symptom Index among men with benign prostate hyperplasia (BPH), urethral obstruction not due to BPH and detrusor hyperreflexia without outlet obstruction.
    Chancellor MB; Rivas DA; Keeley FX; Lotfi MA; Gomella LG
    Br J Urol; 1994 Aug; 74(2):200-3. PubMed ID: 7522872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The volume of the prostate in benign hyperplasia and evaluation of infravesical obstruction].
    Svihra J; Poulsen AL; Schou J
    Bratisl Lek Listy; 1994 Mar; 95(3):113-5. PubMed ID: 7522938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prostatic middle lobe hyperplasia correlates with bladder outflow obstruction: analysis of 131 cases].
    Shen H; Zhou HT; Wu HF; Yu HB; Li BJ; Zhang B; Lin JZ
    Zhonghua Nan Ke Xue; 2011 Jun; 17(6):527-30. PubMed ID: 21735652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.